E-mail a Wiley Online Library Link

D. M. Hotho, J. de Bruijne, M. Spaan, M. A. Treitel, A. Boonstra, R. J. de Knegt, H. L. A. Janssen and H. W. Reesink Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up Journal of Viral Hepatitis 20

Version of Record online: 7 JAN 2013 | DOI: 10.1111/jvh.12012

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field